-
The Czech Republic’s Dedicated Orphan Drug Reimbursement Mechanism 2022-2025: Improvements in Access
Sep 9, 2025, 16:22 PM -
A Review of Utility Data Used in Health Technology Assessments From the Perspective of a Health Technology Assessment Body
Sep 9, 2025, 16:22 PM -
Rising EAP Rejection Rates and Their Impact on Drug Access in France
Sep 9, 2025, 16:22 PM -
Comparing HTA Outcomes and Rationale for Decision Making Between Countries With Mature vs. Newly Founded HTA Systems: Evidence From England, France, and Greece
Sep 9, 2025, 16:22 PM -
Burden of Illness and Healthcare Resource Utilization Among Patients Newly Diagnosed With Amyotrophic Lateral Sclerosis in the United States: A Retrospective, Observational, Cohort Design Study
Sep 9, 2025, 16:22 PM -
Bridging the Survival Extrapolation Gap in Health Economic Models: A Case Study on Spline-Based Survival Analysis Using ML-NMR to Address Complex Hazard Function
Sep 9, 2025, 16:22 PM -
Molecular Testing Strategies and Their Impact on Treatment Decision in HR+/HER2- Metastatic Breast Cancer: A Real-World Analysis From German Centers
Sep 9, 2025, 16:22 PM -
The Artificial Intelligence Era in Health Economic Modeling
Sep 9, 2025, 16:22 PM -
Framing Matters! Implications of Loss Aversion for Communicating Benefits to Patients in Preference Studies (and Beyond)
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review on Economic Evaluations and Cost-Effectiveness of Second-Line Treatment Options for Immune Thrombocytopenia
Sep 9, 2025, 16:22 PM -
Public Spending on Medicines Between 2018 and 2026: Lessons for Designing a New Financing Model in Portugal
Sep 9, 2025, 16:22 PM -
Competing Beyond the First Mover: How Late to Market Analogues Navigate Pricing and Access in Major Global Markets
Sep 9, 2025, 16:22 PM -
The Hidden Clinical and Economic Costs of PPI Treatment Failures in Severe Erosive Esophagitis
Sep 9, 2025, 16:22 PM -
Navigating Uncertainty and Pragmatic Acceptance: Canadian Patient and Public Perspectives on Radiopharmaceutical Therapy in the Context of Whole Health
Sep 9, 2025, 16:22 PM -
Dinutuximab Beta vs. Historical Controls in the Maintenance Therapy of Relapsed Neuroblastoma: Unadjusted and Adjusted Indirect Comparison
Sep 9, 2025, 16:22 PM -
Association of Recurrences With Healthcare Resource Utilization in High-Risk Non-Muscle Invasive Bladder Cancer Patients Across Europe: A Real-World Survey
Sep 9, 2025, 16:22 PM -
Equivalence of Measurement Properties of the Dermatology Life Quality Index (DLQI) Across 13 European Countries
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Evaluation of Combined Cervical Cancer Screening With CINtec PLUS in the Czech Republic
Sep 9, 2025, 16:22 PM -
Estimating the Economic Burden of Potential Chikungunya Outbreaks in Southern Europe
Sep 9, 2025, 16:22 PM -
Mutagenicity of Imazalil, Pyrimethanil, and Thiabendazole With and Without Citrus Oil
Sep 9, 2025, 16:22 PM
